Presentation is loading. Please wait.

Presentation is loading. Please wait.

Jeffrey P. Carpenter, MD, John E. Tomaszewski, MD 

Published byMarlene Brooks Modified over 5 years ago

Similar presentations

Presentation on theme: "Jeffrey P. Carpenter, MD, John E. Tomaszewski, MD "— Presentation transcript:

1 Immunosuppression for human saphenous vein allograft bypass surgery: A prospective randomized trial 
Jeffrey P. Carpenter, MD, John E. Tomaszewski, MD  Journal of Vascular Surgery  Volume 26, Issue 1, Pages (July 1997) DOI: /S (97) Copyright © 1997 Society for Vascular Surgery and International Society for Cardiovascular Surgery, North American Chapter Terms and Conditions

2 Fig. 1 Life-table analysis of primary graft patency data of immunosuppressed (n = 17) and control (n = 23) patients who received saphenous vein allograft bypass grafts. No significant difference between the immunosuppressed and control groups was identified for primary graft patency. Error bars represent the standard error. Journal of Vascular Surgery  , 32-42DOI: ( /S (97) ) Copyright © 1997 Society for Vascular Surgery and International Society for Cardiovascular Surgery, North American Chapter Terms and Conditions

3 Fig. 2 Life-table analysis of limb salvage data for immunosuppressed (n = 17) and control (n = 23) patients who received saphenous vein allograft bypass grafts. No significant difference was found between immunosuppressed and control groups for limb salvage rate. Error bars represent the standard error. Journal of Vascular Surgery  , 32-42DOI: ( /S (97) ) Copyright © 1997 Society for Vascular Surgery and International Society for Cardiovascular Surgery, North American Chapter Terms and Conditions

4 Fig. 3 Development of anti-HLA antibodies after vein allograft bypass grafting in 38 patients. The development of anti-HLA antibodies for individual patients after the bypass procedures suggests a humoral immune response to the allograft and implies the antigenicity of the bypass graft. Journal of Vascular Surgery  , 32-42DOI: ( /S (97) ) Copyright © 1997 Society for Vascular Surgery and International Society for Cardiovascular Surgery, North American Chapter Terms and Conditions

5 Fig. 4 Comparison of primary graft patency in patients with anti-HLA antibodies (positive) vs. patients without anti-HLA antibodies (negative) detected before surgery. The presence of preoperative anti-HLA antibodies significantly predicted bypass graft failure at the 90% but not the 95% significance level. Error bars represent the standard error. Journal of Vascular Surgery  , 32-42DOI: ( /S (97) ) Copyright © 1997 Society for Vascular Surgery and International Society for Cardiovascular Surgery, North American Chapter Terms and Conditions

6 Fig. 5 Biopsy at the time of implantation of a saphenous vein allograft shows apoptosis of the outer layers of the smooth muscle. This is thought to be a preservation/procurement–related phenomenon. Journal of Vascular Surgery  , 32-42DOI: ( /S (97) ) Copyright © 1997 Society for Vascular Surgery and International Society for Cardiovascular Surgery, North American Chapter Terms and Conditions

7 Fig. 6 Human saphenous vein allograft rejection demonstrated in an explanted vein allograft. The inflammatory infiltrate (A) is demonstrated to be predominantly T-lymphocytes on this photomicrograph using a CD3 marker (B). Macrophages (C) and B-lymphocytes (D) are less prevalent (CD68 and L26 markers, respectively). Journal of Vascular Surgery  , 32-42DOI: ( /S (97) ) Copyright © 1997 Society for Vascular Surgery and International Society for Cardiovascular Surgery, North American Chapter Terms and Conditions

8 Fig. 6 Human saphenous vein allograft rejection demonstrated in an explanted vein allograft. The inflammatory infiltrate (A) is demonstrated to be predominantly T-lymphocytes on this photomicrograph using a CD3 marker (B). Macrophages (C) and B-lymphocytes (D) are less prevalent (CD68 and L26 markers, respectively). Journal of Vascular Surgery  , 32-42DOI: ( /S (97) ) Copyright © 1997 Society for Vascular Surgery and International Society for Cardiovascular Surgery, North American Chapter Terms and Conditions

9 Fig. 6 Human saphenous vein allograft rejection demonstrated in an explanted vein allograft. The inflammatory infiltrate (A) is demonstrated to be predominantly T-lymphocytes on this photomicrograph using a CD3 marker (B). Macrophages (C) and B-lymphocytes (D) are less prevalent (CD68 and L26 markers, respectively). Journal of Vascular Surgery  , 32-42DOI: ( /S (97) ) Copyright © 1997 Society for Vascular Surgery and International Society for Cardiovascular Surgery, North American Chapter Terms and Conditions

10 Fig. 6 Human saphenous vein allograft rejection demonstrated in an explanted vein allograft. The inflammatory infiltrate (A) is demonstrated to be predominantly T-lymphocytes on this photomicrograph using a CD3 marker (B). Macrophages (C) and B-lymphocytes (D) are less prevalent (CD68 and L26 markers, respectively). Journal of Vascular Surgery  , 32-42DOI: ( /S (97) ) Copyright © 1997 Society for Vascular Surgery and International Society for Cardiovascular Surgery, North American Chapter Terms and Conditions

Download ppt "Jeffrey P. Carpenter, MD, John E. Tomaszewski, MD "

Similar presentations

The role of arteriovenous shunts in the pathogenesis of varicose veins Howard C. Baron, M.D., Sebastiano Cassaro, M.D. Journal of Vascular Surgery Volume.

The role of arteriovenous shunts in the pathogenesis of varicose veins Howard C. Baron, M.D., Sebastiano Cassaro, M.D. Journal of Vascular Surgery Volume.
Jeffrey P. Carpenter, MD, John E. Tomaszewski, MD 

Jeffrey P. Carpenter, MD, John E. Tomaszewski, MD 
Bypass graft to the contralateral internal jugular vein for venous outflow obstruction of a functioning hemodialysis access fistula  Jeff L. Myers, MD,

Bypass graft to the contralateral internal jugular vein for venous outflow obstruction of a functioning hemodialysis access fistula  Jeff L. Myers, MD,
Is long vein bypass from groin to ankle a durable procedure

Is long vein bypass from groin to ankle a durable procedure
Axillary-to-carotid artery bypass grafting for symptomatic severe common carotid artery occlusive disease  Joseph P. Archie, PhD, MD  Journal of Vascular.

Axillary-to-carotid artery bypass grafting for symptomatic severe common carotid artery occlusive disease  Joseph P. Archie, PhD, MD  Journal of Vascular.
Lloyd M. Taylor, M.D., Edward S. Phinney, M.D., John M. Porter, M.D. 

Lloyd M. Taylor, M.D., Edward S. Phinney, M.D., John M. Porter, M.D. 
Pedal bypass versus tibial bypass with autogenous vein: A comparison of outcome and hemodynamic results  Joseph R. Schneider, MD, PhD, Daniel B. Walsh,

Pedal bypass versus tibial bypass with autogenous vein: A comparison of outcome and hemodynamic results  Joseph R. Schneider, MD, PhD, Daniel B. Walsh,
Descending thoracic aorta to iliofemoral artery bypass grafting: A role for primary revascularization for aortoiliac occlusive disease?  Marc A. Passman,

Descending thoracic aorta to iliofemoral artery bypass grafting: A role for primary revascularization for aortoiliac occlusive disease?  Marc A. Passman,
Jeffrey P. Carpenter, MD, John E. Tomaszewski, MD 

Jeffrey P. Carpenter, MD, John E. Tomaszewski, MD 
A new valvulotome for in situ bypass grafts

A new valvulotome for in situ bypass grafts
Enrique Criado, MD, Steven J. Burnham, MD, Ellis A

Enrique Criado, MD, Steven J. Burnham, MD, Ellis A
Jeffrey R. Rubin, M.D., James M. Malone, M.D., Jerry Goldstone, M.D. 

Jeffrey R. Rubin, M.D., James M. Malone, M.D., Jerry Goldstone, M.D. 
Axillofemoral bypass: A tool with a limited role

Axillofemoral bypass: A tool with a limited role
Malcolm O. Perry, MD, Richard Kempczinski, MD 

Malcolm O. Perry, MD, Richard Kempczinski, MD 
Axillopopliteal bypass for limb salvage

Axillopopliteal bypass for limb salvage
Cryopreserved saphenous vein graft in infrainguinal bypass

Cryopreserved saphenous vein graft in infrainguinal bypass
Peripheral atherectomy with the rotablator: A multicenter report

Peripheral atherectomy with the rotablator: A multicenter report
A prospective randomized trial comparing vein with polytetrafluoroethylene in above- knee femoropopliteal bypass grafting  Desiree H.C. Burger, MDa, A.Pieter.

A prospective randomized trial comparing vein with polytetrafluoroethylene in above- knee femoropopliteal bypass grafting  Desiree H.C. Burger, MDa, A.Pieter.
Six-year prospective multicenter randomized comparison of autologous saphenous vein and expanded polytetrafluoroethylene grafts in infrainguinal arterial.

Six-year prospective multicenter randomized comparison of autologous saphenous vein and expanded polytetrafluoroethylene grafts in infrainguinal arterial.
Long-term results of the treatment of aortic graft infection by in situ replacement with femoral popliteal vein grafts  Ahsan T. Ali, MD, J. Gregory Modrall,

Long-term results of the treatment of aortic graft infection by in situ replacement with femoral popliteal vein grafts  Ahsan T. Ali, MD, J. Gregory Modrall,

Similar presentations

Ads by Google